Gsk spero therapeutics
WebSep 22, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, … WebNov 8, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and …
Gsk spero therapeutics
Did you know?
WebMar 30, 2024 · Exclusive license agreement with GSK for tebipenem HBr provided Spero with $66 million upfront, a $9 million direct equity investment, and eligibility for future milestone payments and tiered royalties ... Conference call and live webcast at 4:30 p.m. ET today. CAMBRIDGE, Mass., March 30, 2024 (GLOBE NEWSWIRE) -- Spero … WebSep 23, 2024 · Spero does not have any marketed drugs in its portfolio. A partnership with a pharma giant like GSK, which has huge cash resources and industry expertise and a global commercial presence, will...
WebWe are a company where outstanding people can thrive. Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology Purpose, strategy and culture Why invest in GSK? Infectious diseases 1 in 3 of us will be affected by shingles in our lifetime Go to infectious diseases HIV 38m WebSep 22, 2024 · GSK agreed to purchase 7.45 million Spero shares at about $1.20805 per share, which will not exceed 19.99% ownership of Spero by GSK and its affiliates, the …
WebSep 22, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for bacterial infections, including multi-drug resistant bacterial infections and rare diseases. WebSep 22, 2024 · Spero Therapeutics, Inc. 22 September 2024, 2:00 am · 8-min read The exclusive license allows GSK to commercialize tebipenem HBr in all territories, except Japan and certain other Asian...
WebSep 22, 2024 · GSK is also buying $9 million in Spero stock at about $1.21 per share, a roughly 48% premium to the struggling biotech’s closing price on Thursday. The deal …
WebSep 22, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, … irene woods memphisWeb3 rows · Sep 22, 2024 · Spero Therapeutics receives $66 million upfront, with potential for future milestone payments, ... irene worthamWebSep 21, 2024 · · GSK to purchase $9 million in shares of Spero common stock . GSK plc (LSE/NYSE: GSK) and Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced … ordering face masks from amazonWebSep 22, 2024 · The Deal Comes with an Investment To go along with this, GSK is investing $9 million in Spero Therapeutics through a stock purchase. This has it acquiring 7.45 … ordering facility nc 13257WebNov 14, 2024 · Entered into and closed exclusive license agreement with GSK for tebipenem HBr, pursuant to which Spero receives $66 million upfront, and a $9 million direct equity investment in Spero shares of common stock, with potential for future milestone payments and tiered royalties ordering eyeglasses with prescriptionWebFeb 16, 2024 · GlaxoSmithKline Plc Johnson and Johnson Merck and Co. Inc. Novartis AG ... Johnson and Johnson, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Spero Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the hospital infection therapeutics market analysis report includes ... irene wrestlingWebSep 22, 2024 · Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, … irene wortham asheville